Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Macor

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Pharmaceutics|September 23, 2022
Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell MalignanciesSara Bozzer, Michele Dal Bo, Maria Cristina Grimaldi, et al.
Current Pharmaceutical Design|August 12, 2008
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignanciesPaolo Macor, Erika Secco, Sonia Zorzet, et al.
Pharmaceutics|December 23, 2022
Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune SystemSonia Panico, Sara Capolla, Sara Bozzer, et al.
Molecular Immunology|June 2, 2009
Complement in human diseases: Lessons from complement deficienciesMarina Botto, Michael Kirschfink, Paolo Macor, et al.
Frontiers in Immunology|March 10, 2023
C9 immunostaining as a tissue biomarker for periprosthetic joint infection diagnosisAnn-Kathrin Meinshausen, Jacqueline Färber, Sebastian Illiger, et al.
The Journal of Biological Chemistry|July 1, 2021
An allosteric redox switch in domain V of β<sub>2</sub>-glycoprotein I controls membrane binding and anti-domain I autoantibody recognitionSuresh Kumar, Mathivanan Chinnaraj, William Planer, et al.
Cancer Research|April 6, 2006
Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinomaPaolo Macor, Delia Mezzanzanica, Chiara Cossetti, et al.
International Journal of Molecular Sciences|November 27, 2024
Evidence of a Lytic Pathway in an Invertebrate Complement System: Identification of a Terminal Complement Complex Gene in a Colonial Tunicate and Its Evolutionary ImplicationsLoriano Ballarin, Anna Peronato, Davide Malagoli, et al.
Journal of Colloid and Interface Science|July 21, 2020
Cubosomes stabilized by a polyphosphoester-analog of Pluronic F127 with reduced cytotoxicityMarco Fornasier, Stefania Biffi, Barbara Bortot, et al.
Frontiers in Immunology|March 14, 2025
β2GPI-targeted polymeric nanoparticles form a protective layer to prevent vascular thrombosis in an anti-phospholipid syndrome modelPaolo Durigutto, Maria Cristina Grimaldi, Sara Bozzer, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Pharmaceutics|September 23, 2022
Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell MalignanciesSara Bozzer, Michele Dal Bo, Maria Cristina Grimaldi, et al.
Current Pharmaceutical Design|August 12, 2008
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignanciesPaolo Macor, Erika Secco, Sonia Zorzet, et al.
Pharmaceutics|December 23, 2022
Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune SystemSonia Panico, Sara Capolla, Sara Bozzer, et al.
Molecular Immunology|June 2, 2009
Complement in human diseases: Lessons from complement deficienciesMarina Botto, Michael Kirschfink, Paolo Macor, et al.
Frontiers in Immunology|March 10, 2023
C9 immunostaining as a tissue biomarker for periprosthetic joint infection diagnosisAnn-Kathrin Meinshausen, Jacqueline Färber, Sebastian Illiger, et al.
The Journal of Biological Chemistry|July 1, 2021
An allosteric redox switch in domain V of β<sub>2</sub>-glycoprotein I controls membrane binding and anti-domain I autoantibody recognitionSuresh Kumar, Mathivanan Chinnaraj, William Planer, et al.
Cancer Research|April 6, 2006
Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinomaPaolo Macor, Delia Mezzanzanica, Chiara Cossetti, et al.
International Journal of Molecular Sciences|November 27, 2024
Evidence of a Lytic Pathway in an Invertebrate Complement System: Identification of a Terminal Complement Complex Gene in a Colonial Tunicate and Its Evolutionary ImplicationsLoriano Ballarin, Anna Peronato, Davide Malagoli, et al.
Journal of Colloid and Interface Science|July 21, 2020
Cubosomes stabilized by a polyphosphoester-analog of Pluronic F127 with reduced cytotoxicityMarco Fornasier, Stefania Biffi, Barbara Bortot, et al.
Frontiers in Immunology|March 14, 2025
β2GPI-targeted polymeric nanoparticles form a protective layer to prevent vascular thrombosis in an anti-phospholipid syndrome modelPaolo Durigutto, Maria Cristina Grimaldi, Sara Bozzer, et al.
Pageof 8